chr13-111342824-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152324.3(TEX29):āc.308A>Gā(p.Glu103Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152324.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TEX29 | NM_152324.3 | c.308A>G | p.Glu103Gly | missense_variant | 5/6 | ENST00000283547.2 | NP_689537.1 | |
TEX29 | NM_001303133.1 | c.377A>G | p.Glu126Gly | missense_variant | 6/7 | NP_001290062.1 | ||
TEX29 | XM_017020387.2 | c.389A>G | p.Glu130Gly | missense_variant | 5/6 | XP_016875876.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TEX29 | ENST00000283547.2 | c.308A>G | p.Glu103Gly | missense_variant | 5/6 | 1 | NM_152324.3 | ENSP00000283547 | P1 | |
TEX29 | ENST00000497241.5 | c.*279A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 5 | ENSP00000431661 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727236
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.308A>G (p.E103G) alteration is located in exon 5 (coding exon 4) of the TEX29 gene. This alteration results from a A to G substitution at nucleotide position 308, causing the glutamic acid (E) at amino acid position 103 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.